Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Nab Pacliage Injection
Manufacturer/Marketed By : AEGIS PHARMACEUTICALS
$129.78 $32.45
Nab Pacliage Injection is a specialized formulation combining the anti-cancer drug paclitaxel with human albumin, a protein naturally found in the body. This novel combination belongs to the therapeutic class...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
PACLITAXEL,HUMAN ALBUMIN
Active Pharmaceutical Ingredient
Nab Pacliage Injection
129.78$
32.45$
Nab Pacliage Injection is a specialized formulation combining the anti-cancer drug paclitaxel with human albumin, a protein naturally found in the body. This novel combination belongs to the therapeutic class of antineoplastic agents and is primarily used to treat various cancers, including metastatic breast cancer, non-small cell lung cancer (NSCLC), and advanced pancreatic cancer. By leveraging human albumin, the drug ensures better solubility and delivery of paclitaxel, enhancing its therapeutic effects while reducing solvent-related side effects. Nab Pacliage Injection is administered via intravenous infusion and should be used under the supervision of a qualified healthcare professional. Safety precautions are essential, as the drug is contraindicated in patients with hypersensitivity to its components and those with severe liver impairment. Pregnant and breastfeeding women are advised to avoid using this medication due to its potential risks. Warnings associated with Nab Pacliage Injection include myelosuppression (reduced bone marrow activity), risk of infections, and potential nerve damage. Careful monitoring and adherence to dosing schedules are crucial to achieving the best possible outcomes.
Active Pharmaceutical Ingredient
Uses
• Metastatic breast cancer
• Non-small cell lung cancer (NSCLC)
• Advanced pancreatic cancer
Benefits
Paclitaxel, the active ingredient in this formulation, works by disrupting the division and growth of cancer cells. It targets the microtubules within the cells, which are essential for cell division. By stabilizing these structures, the drug prevents cancer cells from completing their lifecycle, leading to cell death. The inclusion of human albumin enhances drug delivery to tumors, making the treatment more effective and reducing side effects commonly associated with traditional solvents.
Side Effects
Common Side Effects:
Most Common Side Effects
• Severe allergic reactions (rash, swelling, difficulty breathing)
• Peripheral neuropathy (numbness or tingling in hands/feet)
• Neutropenia (low white blood cell count)
• Severe liver enzyme elevation
Common Side Effects
• Nausea and vomiting
• Fatigue
• Hair loss
• Muscle or joint pain
• Mild diarrhea
How To Use
The dose depends on the type and stage of cancer. A healthcare professional will determine the appropriate schedule. Nab Pacliage Injection is administered as an intravenous infusion. It can be taken without regard to meals.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended while taking Nab Pacliage Injection as the drug can pass into breast milk and harm the infant.
• Alcohol: Alcohol consumption should be avoided as it may interact with the medication or worsen side effects.
• Liver: Dose adjustments may be required for patients with liver impairment. Routine liver function tests are advised.
• Lungs: Patients with pre-existing lung issues should discuss their condition before starting treatment, as it may exacerbate breathing difficulties.
• Driving: Nab Pacliage Injection may cause dizziness, fatigue, or neuropathy, affecting the ability to drive safely.
• Pregnancy: Nab Pacliage Injection can harm the unborn baby and should not be used during pregnancy unless absolutely necessary.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.